RESUMEN
BACKGROUND: Percutaneous renal denervation (RDN) has recently been introduced as a treatment for therapy-resistant hypertension. Also, it has been suggested that RDN may be beneficial for other conditions characterised by increased sympathetic nerve activity. There are still many uncertainties with regard to efficacy, safety, predictors for success and long-term effects. To answer these important questions, we initiated a Dutch RDN registry aiming to collect data from all RDN procedures performed in the Netherlands. METHODS: The Dutch RDN registry is an ongoing investigator-initiated, prospective, multicentre cohort study. Twenty-six Dutch hospitals agreed to participate in this registry. All patients who undergo RDN, regardless of the clinical indication or device that is used, will be included. Data are currently being collected on eligibility and screening, treatment and follow-up. RESULTS: Procedures have been performed since August 2010. At present, data from 306 patients have been entered into the database. The main indication for RDN was hypertension (n = 302, 99%). Patients had a mean office blood pressure of 177/100 (±29/16) mmHg with a median use of three (range 0-8) blood pressure lowering drugs. Mean 24-hour blood pressure before RDN was 157/93 (±18/13) mmHg. RDN was performed with different devices, with the Simplicity™ catheter currently used most frequently. CONCLUSION: Here we report on the rationale and design of the Dutch RDN registry. Enrolment in this investigator-initiated study is ongoing. We present baseline characteristics of the first 306 participants.
Asunto(s)
Hipertensión/cirugía , Sistema de Registros , Arteria Renal/cirugía , Simpatectomía/estadística & datos numéricos , Anciano , Antihipertensivos/uso terapéutico , Presión Sanguínea , Femenino , Humanos , Hipertensión/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Periodo Preoperatorio , Estudios Prospectivos , Arteria Renal/inervación , Simpatectomía/métodos , Tiempo , Resultado del TratamientoRESUMEN
Legionella pneumophila is an intracellularly-growing microorganism and the causative agent of Legionnaires' disease; this disease owes its name to the epidemic among American war veterans in Philadelphia in 1976. The analysis ofthe epidemic in Philadelphia revealed--retrospectively--that unlike beta-lactam antibiotica, erythromycin and tetracyclines provided protection against an unfavourable outcome. Despite the absence of prospective, blinded, randomised clinical trials, a well-founded choice for the antibiotic treatment of patients with a Legionella infection can be made using the evidence from in-vitro and cell culture studies, as well as studies in animal models. Although erythromycin, either or not in combination with rifampicin, is still recommended, there is not enough scientific evidence to support this as a first choice drug treatment. The available evidence suggests that quinolones (the most researched are ciprofloxacin and levofloxacin) are the treatment of choice in the case of severe Legionella pneumonia. Newer macrolides (especially azithromycin) have been shown to have some additional beneficial effect. However, the lack of an intravenous formulation limits the use of newer macrolides in severely ill patients.
Asunto(s)
Antibacterianos/uso terapéutico , Legionella pneumophila/efectos de los fármacos , Enfermedad de los Legionarios/tratamiento farmacológico , Eritromicina/uso terapéutico , Humanos , Pruebas de Sensibilidad Microbiana , Tetraciclina/uso terapéutico , Resultado del TratamientoRESUMEN
In this case report, we describe a 33-year-old woman with a history of two unprovoked thrombo-embolic events presenting with acute myocardial ischaemia. She had a normal coronary angiogram (CAG). The diagnosis primary antiphospholipid syndrome (APS), an acquired hypercoagulability disorder, was established by the presence of antibodies directed against phospholipids. The primary APS should be considered as a cause of myocardial ischaemia in patients with a normal CAG and a history of unprovoked thrombo-embolic events.
Asunto(s)
Síndrome Antifosfolípido/complicaciones , Isquemia Miocárdica/etiología , Adulto , Angiografía Coronaria , Femenino , Humanos , Isquemia Miocárdica/diagnóstico por imagenRESUMEN
A 42-year-old man had ischaemia of three fingers of his left hand caused by thromboangiitis obliterans (Buerger's disease).
Asunto(s)
Dedos/patología , Iloprost/uso terapéutico , Fumar/efectos adversos , Tromboangitis Obliterante/diagnóstico , Vasodilatadores/uso terapéutico , Adulto , Diagnóstico Diferencial , Dedos/irrigación sanguínea , Humanos , Isquemia/complicaciones , Masculino , Tromboangitis Obliterante/tratamiento farmacológicoRESUMEN
A 48-year-old woman with exanthema, pruritus and eosinophilia was found upon further examination to have a small-cell bronchus carcinoma; after chemotherapy and radiotherapy there was an almost complete response and the skin symptoms disappeared. A 70-year-old man who was recently treated due to primary malignant fibrous histiocytoma associated with eosinophilia became cachectic and anaemic. He was found to have a metastased leiomyosarcoma and died shortly afterwards. Worldwide the most common cause of eosinophilia is a parasitic infection, whereas in Western Europe the most common causes are allergic reactions and medicine use. Paraneoplastic symptoms are present in 7-10% of adults with cancer. However, the frequency of eosinophilia as a paraneoplastic phenomenon is unknown. It is important to recognise this phenomenon of paraneoplastic eosinophilia for the timely diagnosis and treatment of the underlying disease.
Asunto(s)
Carcinoma de Células Pequeñas/complicaciones , Eosinofilia/etiología , Leiomiosarcoma/complicaciones , Neoplasias Pulmonares/complicaciones , Anciano , Carcinoma de Células Pequeñas/diagnóstico , Resultado Fatal , Femenino , Humanos , Leiomiosarcoma/diagnóstico , Leiomiosarcoma/patología , Neoplasias Pulmonares/diagnóstico , Masculino , Persona de Mediana Edad , PronósticoRESUMEN
Two 41-year-old women, who had previously been splenectomized, were admitted to the intensive-care unit due to fulminant sepsis. On admission, petechiae and ecchymoses characterised the clinical presentation of both patients. Laboratory tests revealed the presence of renal insufficiency and thrombocytopenia with disseminated intravascular coagulation. Streptococcus pneumoniae with serotypes (24 and 38) not included in the current polyvalent pneumococcal vaccine were found in blood cultures from both patients. One patient died as a result of a refractory septic shock. The other patient, who had never been vaccinated with the polyvalent pneumococcal vaccine, survived the sepsis. The clinical course of a fulminant Streptococcus pneumoniae sepsis in both asplenic patients underlines the importance of vaccination. It is also important to educate the patient about seeking immediate medical help if an infection is suspected on the basis of these symptoms. Vaccination does not provide complete protection.